Giacomo Desantis

Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2025

miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.

miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.

Journal: Leukemia
Published: March 14, 2023

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.

Journal: Nature communications
Published: December 16, 2021

CD14 positive cells accelerate hematopoietic stem cell engraftment.

CD14 positive cells accelerate hematopoietic stem cell engraftment.

Journal: Bone marrow transplantation
Published: June 15, 2021

Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.

Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.

Journal: EMBO molecular medicine
Published: October 16, 2020

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

Journal: Haematologica
Published: September 14, 2019

Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.

Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.

Journal: Stem cell reports
Published: November 22, 2016

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.

Journal: The Journal of experimental medicine
Published: April 30, 2014
Showing 1-8 of 8

Last Updated: 09/26/2026